Durvalumab 61434-0038-02
- Manufacturer
- Catalent Indiana, Llc
- Dosage Form
- Injection, Solution
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2017
- Listing Expires
- December 31, 2026
Need to source Durvalumab? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Durvalumab | 120 mg/2.4mL |
Selected Package
61434-0038-02Selected288 VIAL in 1 CASE (61434-038-02) / 2.4 mL in 1 VIAL